HCW Biologics Inc.

HCW Biologics Inc.

HCWB
HCW Biologics Inc.US flagNASDAQ Global Market
1.68
USD
-0.11
- -
3.50MMarket Cap

Income Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
4
- -
7
3
3
- -
+ Sales & Services Revenue
- -
4
- -
7
3
3
- -
- Cost of Revenue
- -
- -
- -
4
2
2
- -
+ Cost of Goods & Services
- -
- -
- -
4
2
2
- -
Gross Profit
- -
- -
- -
3
1
1
- -
+ Other Operating Income
- -
-4
- -
- -
- -
- -
- -
- Operating Expenses
7
10
13
18
26
29
11
+ Selling, General & Admin
2
2
5
8
13
22
6
+ Research & Development
5
7
8
9
8
6
5
+ Other Operating Expense
- -
- -
- -
- -
6
- -
- -
Operating Income (Loss)
-7
-6
-13
-15
-26
-28
-11
- Non-Operating (Income) Loss
- -
- -
-1
- -
-1
2
-3
+ Interest Expense, Net
- -
- -
-1
- -
- -
1
1
+ Interest Expense
- -
- -
- -
- -
- -
1
1
- Interest Income
- -
- -
1
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
-1
1
-5
Pretax Income
-7
-6
-13
-15
-25
-30
-8
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-7
-6
-13
-15
-25
-30
-8
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-7
-6
-13
-15
-25
-30
-8
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-7
-6
-13
-15
-25
-30
-8
- Preferred Dividends
- -
1
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-8
-7
-13
-15
-25
-30
-8
EBIT
-7
-6
-13
-15
-26
-28
-11
EBITDA
-7
-5
-13
-14
-25
-26
-10
EBITDA Margin (%)
- -
-128.1
- -
-213.64
-865.02
-1,030.27
-18,836.7
EBITA
-7
-6
-13
-15
-26
-28
-11
Gross Margin (%)
- -
100
- -
38.48
19.72
37.38
20
Operating Margin (%)
- -
-142.07
- -
-224.32
-904.96
-1,076.41
-20,757.65
Profit Margin (%)
- -
-141.53
- -
-221.67
-879.52
-1,169.7
-14,677.14
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
1
1
1
1
1
1
Basic Weighted Avg Shares
1
1
- -
1
1
1
2
Basic EPS, GAAP
-12.74
-9.89
-27.41
-16.64
-27.83
-30.96
-3.79
Basic EPS from Cont Ops
-11.94
-8.11
-27.41
-16.64
-27.83
-30.96
-3.79
Diluted Weighted Avg Shares
1
1
- -
1
1
1
2
Diluted EPS, GAAP
-12.74
-9.89
-27.41
-16.64
-27.83
-30.96
-3.79
Diluted EPS from Cont Ops
-11.94
-8.11
-27.41
-16.64
-27.83
-30.96
-3.79

Balance Sheet (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
8
12
40
34
6
6
2
+ Cash, Cash Equivalents & STI
7
8
37
32
4
5
2
+ Cash & Cash Equivalents
7
8
12
22
4
5
2
+ ST Investments
- -
- -
25
10
- -
- -
- -
+ Accounts & Notes Receiv
- -
2
- -
- -
2
1
- -
+ Accounts Receivable, Net
- -
2
- -
- -
2
1
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
1
4
2
1
- -
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
2
3
13
13
22
25
22
+ Property, Plant & Equip, Net
2
2
1
11
20
23
21
+ Property, Plant & Equip
3
3
3
13
23
27
25
- Accumulated Depreciation
1
1
2
2
3
4
4
+ LT Investments & Receivables
- -
2
12
2
2
2
1
+ LT Investments
- -
2
12
2
2
2
1
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
Total Assets
10
15
54
47
29
30
25
+ Payables & Accruals
1
1
2
3
9
23
14
+ Accounts Payable
- -
- -
- -
1
6
22
13
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
2
2
3
1
1
+ ST Debt
- -
- -
- -
- -
- -
6
7
+ ST Borrowings
- -
- -
- -
- -
- -
6
7
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
1
1
2
3
9
30
21
+ LT Debt
- -
- -
- -
6
6
7
- -
+ LT Borrowings
- -
- -
- -
6
6
7
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
1
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
1
Total Noncurrent Liabilities
- -
- -
- -
6
6
7
1
Total Liabilities
1
1
2
9
15
37
22
+ Preferred Equity and Hybrid Capital
19
31
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
82
83
84
94
111
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
82
83
84
94
111
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-10
-17
-31
-46
-71
-101
-109
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
9
14
51
37
13
-7
3
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
9
14
51
37
13
-7
3
Total Liabilities & Equity
10
15
54
47
29
30
25
Shares Outstanding
1
1
1
1
1
1
3
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
Net Debt
-7
-8
-12
-16
3
9
5
Net Debt to Equity
-81.73
-58.73
-22.91
-42.52
20.13
-133.2
175.67
Tangible Common Equity Ratio
-96.13
-108.57
95.66
79.96
47.21
-22.39
11.28
Current Ratio
7.53
12.14
17.44
11.52
0.73
0.19
0.11
Cash Conversion Cycle
- -
- -
- -
-49.03
-465.97
-3,085.19
-147,158.24

Cash Flow Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-7
-6
-13
-15
-25
-30
-8
+ Depreciation & Amortization
- -
1
1
1
1
1
1
+ Non-Cash Items
- -
- -
- -
1
6
1
-4
+ Stock-Based Compensation
- -
- -
- -
1
1
1
1
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
2
+ Other Non-Cash Adj
- -
- -
- -
- -
5
- -
-6
+ Chg in Non-Cash Work Cap
- -
-5
1
2
-5
14
-3
+ (Inc) Dec in Accts Receiv
- -
-2
2
- -
-1
1
1
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-1
-2
-3
2
-5
1
- -
+ Inc (Dec) in Accts Payable
1
-1
2
- -
2
12
-3
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-7
-10
-11
-10
-23
-14
-13
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
- -
- -
-10
-6
- -
- -
+ Acq of Fixed Prod Assets
-1
- -
- -
-10
-6
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
56
- -
- -
6
8
+ Increase in Capital Stock
- -
- -
56
- -
- -
6
8
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-35
25
10
- -
- -
+ Dec in LT Investment
- -
- -
- -
25
10
- -
- -
+ Inc in LT Investment
- -
- -
-35
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
- -
-35
15
4
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
1
- -
6
- -
7
- -
+ Cash From Debt
- -
1
- -
6
- -
7
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
13
11
-7
- -
- -
2
3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
13
12
49
6
- -
16
11
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
5
1
3
11
-19
1
-3
EBITDA
-7
-5
-13
-14
-25
-26
-10
EBITDA Margin (%)
- -
-128.1
- -
-213.64
-865.02
-1,030.27
-18,836.7
Free Cash Flow
-8
-11
-11
-21
-29
-14
-13
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
1
-42
-14
-29
-8
-13
Free Cash Flow per Basic Share
-13.47
-14.85
-23.49
-23.07
-31.97
-14.94
-6.38
Price/Free Cash Flow
- -
- -
-3.98
-618.03
-2.71
-1.24
-0.15
Cash Flow to Net Income
0.93
1.8
0.85
0.7
0.9
0.47
1.68
Capital Expenditures
-1
- -
- -
-10
-6
- -
- -